secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2024-12-06T23:59:59+00:00
Accession:  0001193125-24-272533
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma stockholders elect directors and approve preferred stock authorization at 2024 annual meeting
--------------------------------------------------------------------------------

- Directors J. Kevin Buchi and Peter Francis elected with 17.3M and 16.5M votes respectively.
- Ratification of independent auditor passed with 17,978,704 votes for, 260 against.
- Advisory vote on executive compensation approved with 17,307,680 votes for.
- Amendment to authorize up to 5,000,000 shares of preferred stock approved with 15,313,718 votes for (85% of votes cast).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524272533/0001193125-24-272533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524272533/d540210d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-272533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer